SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-027521
Filing Date
2023-06-12
Accepted
2023-06-12 16:49:48
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A itrm_defa14a_pre-emption.htm DEFA14A 35158
2 GRAPHIC img18137340_0.jpg GRAPHIC 1820035
3 GRAPHIC img18137340_1.jpg GRAPHIC 971696
  Complete submission text file 0000950170-23-027521.txt   3880670
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38503 | Film No.: 231008793
SIC: 2834 Pharmaceutical Preparations